Compounds > 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrakis(methylenephosphonic acid)
Page last updated: 2024-09-03

1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrakis(methylenephosphonic acid) and lutetium

1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrakis(methylenephosphonic acid) has been researched along with lutetium in 3 studies

Compound Research Comparison

Studies
(1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrakis(methylenephosphonic acid))		Trials
(1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrakis(methylenephosphonic acid))		Recent Studies (post-2010)
(1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrakis(methylenephosphonic acid))		Studies
(lutetium)		Trials
(lutetium)		Recent Studies (post-2010) (lutetium)
25481,19244844

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Banerjee, S; Chakraborty, S; Das, T; Pillai, MR; Samuel, G; Sarma, HD; Unni, PR; Venkatesh, M1
Chakraborty, S; Chakravarty, R; Dash, A; Kamaleshwaran, K; Radhakrishnan, E; Rajeswari, A; Sarma, HD; Shinto, AS; Vimalnath, KV1
Arani, SS; Maraghe, MG; Mehrabi, M; Salek, N; Samani, AB; Vosoghi, S1

Other Studies

3 other study(ies) available for 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrakis(methylenephosphonic acid) and lutetium

ArticleYear
177Lu-labeled cyclic polyaminophosphonates as potential agents for bone pain palliation.
    Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine, 2002, Volume: 57, Issue:2

    Topics: Animals; Bone Neoplasms; Heterocyclic Compounds, 1-Ring; Lutetium; Organophosphonates; Organophosphorus Compounds; Pain; Palliative Care; Radioisotopes; Radiopharmaceuticals; Rats; Rats, Wistar; Tissue Distribution

2002
A "mix-and-use" approach for formulation of human clinical doses of
    Journal of labelled compounds & radiopharmaceuticals, 2017, Volume: 60, Issue:9

    Topics: Animals; Bone Neoplasms; Cancer Pain; Durapatite; Humans; Lutetium; Male; Organophosphorus Compounds; Pharmacy Service, Hospital; Radioisotopes; Rats; Tissue Distribution

2017
Preparation and Dosimetry Evaluation of a Carrier- Free 90Y Labeled DOTMP as a Promising Agent for Bone Marrow Ablation.
    Current radiopharmaceuticals, 2018, Volume: 11, Issue:2

    Topics: Ablation Techniques; Animals; Bone Marrow; Femur; Lutetium; Mice; Models, Biological; Organophosphorus Compounds; Radiation Dosage; Radioisotopes; Rats, Wistar; Samarium; Tissue Distribution; Yttrium Radioisotopes

2018